SEC Comment Letter for GH Research (GHRS) — May 15, 2026
GH Research PLC
Date: May 15, 2026 · CIK: 0001855129 · Accession: 0000000000-26-004994
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295872
Letter
Re: GH Research PLC Registration Statement on Form F-3 Filed May 14, 2026 File No. 333-295872 Dear Velichka Valcheva: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions.
May 15, 2026
Velichka Valcheva Chief Executive Officer GH Research PLC Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Deanna Kirkpatrick
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 15, 2026 Velichka Valcheva Chief Executive Officer GH Research PLC Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland Re: GH Research PLC Registration Statement on Form F-3 Filed May 14, 2026 File No. 333-295872 Dear Velichka Valcheva: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Deanna Kirkpatrick </TEXT> </DOCUMENT>